ARQT
Price
$14.37
Change
+$0.86 (+6.37%)
Updated
Jun 6 closing price
Capitalization
1.71B
67 days until earnings call
KRYS
Price
$136.94
Change
+$4.32 (+3.26%)
Updated
Jun 6 closing price
Capitalization
3.96B
65 days until earnings call
Interact to see
Advertisement

ARQT vs KRYS

Header iconARQT vs KRYS Comparison
Open Charts ARQT vs KRYSBanner chart's image
Arcutis Biotherapeutics
Price$14.37
Change+$0.86 (+6.37%)
Volume$2.44M
Capitalization1.71B
Krystal Biotech
Price$136.94
Change+$4.32 (+3.26%)
Volume$265.91K
Capitalization3.96B
ARQT vs KRYS Comparison Chart
Loading...
ARQT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARQT vs. KRYS commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARQT is a StrongBuy and KRYS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (ARQT: $14.37 vs. KRYS: $136.94)
Brand notoriety: ARQT and KRYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARQT: 112% vs. KRYS: 74%
Market capitalization -- ARQT: $1.71B vs. KRYS: $3.96B
ARQT [@Biotechnology] is valued at $1.71B. KRYS’s [@Biotechnology] market capitalization is $3.96B. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARQT’s FA Score shows that 0 FA rating(s) are green whileKRYS’s FA Score has 0 green FA rating(s).

  • ARQT’s FA Score: 0 green, 5 red.
  • KRYS’s FA Score: 0 green, 5 red.
According to our system of comparison, KRYS is a better buy in the long-term than ARQT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARQT’s TA Score shows that 6 TA indicator(s) are bullish while KRYS’s TA Score has 4 bullish TA indicator(s).

  • ARQT’s TA Score: 6 bullish, 2 bearish.
  • KRYS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ARQT is a better buy in the short-term than KRYS.

Price Growth

ARQT (@Biotechnology) experienced а +10.20% price change this week, while KRYS (@Biotechnology) price change was +8.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

ARQT is expected to report earnings on Aug 13, 2025.

KRYS is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($3.96B) has a higher market cap than ARQT($1.71B). ARQT YTD gains are higher at: 3.159 vs. KRYS (-12.588). KRYS has higher annual earnings (EBITDA): 140M vs. ARQT (-101.07M). KRYS has more cash in the bank: 617M vs. ARQT (198M). KRYS has less debt than ARQT: KRYS (9.66M) vs ARQT (111M). KRYS has higher revenues than ARQT: KRYS (333M) vs ARQT (213M).
ARQTKRYSARQT / KRYS
Capitalization1.71B3.96B43%
EBITDA-101.07M140M-72%
Gain YTD3.159-12.588-25%
P/E RatioN/A32.84-
Revenue213M333M64%
Total Cash198M617M32%
Total Debt111M9.66M1,149%
FUNDAMENTALS RATINGS
KRYS: Fundamental Ratings
KRYS
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
46
SMR RATING
1..100
57
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARQTKRYS
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
77%
Declines
ODDS (%)
Bearish Trend 17 days ago
89%
Bearish Trend 17 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ARQT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVOYX18.770.15
+0.81%
Macquarie Mid Cap Income Opps Y
FAGAX181.79N/A
N/A
Fidelity Advisor Growth Opps A
TAAGX11.99N/A
N/A
Timothy Plan Small/Mid Cap Growth Cl A
LSVAX18.13N/A
N/A
Loomis Sayles Small Cap Value Admin
FAZYX14.17N/A
N/A
Fidelity Advisor Multi-Asset Income M

ARQT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARQT has been loosely correlated with NRIX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ARQT jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARQT
1D Price
Change %
ARQT100%
+6.37%
NRIX - ARQT
45%
Loosely correlated
+2.24%
KRYS - ARQT
43%
Loosely correlated
+3.26%
BEAM - ARQT
43%
Loosely correlated
+9.26%
ROIV - ARQT
43%
Loosely correlated
+0.27%
IDYA - ARQT
42%
Loosely correlated
+2.99%
More